Sentire
Commercial- Indications
- General surgery, Urology, Gynecology, Thoracic surgery
Company intelligence / Profile preview
Cornerstone Robotics has developed the Sentire Endoscopic Surgical System, which has completed multi-center clinical trials in urology, general surgery, gynecology, and thoracic surgeries. The system received NMPA approval in China in September 2024 and is now commercially available there. The company is expanding internationally with new sites established in the UK to support research and market entry into Europe. Clinical results have been positive across multiple specialties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cornerstone Robotics.